58 related articles for article (PubMed ID: 27084915)
1. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study.
Geraldes R; Santos M; Ponte C; Craven A; Barra L; Robson JC; Hammam N; Springer J; Henes J; Hocevar A; Putaala J; Santos E; Rajasekhar L; Daikeler T; Karadag O; Costa A; Khalidi N; Pagnoux C; Canhão P; Melo TPE; Fonseca AC; Ferro JM; Fonseca JE; Suppiah R; Watts RA; Grayson P; Merkel PA; Luqmani RA;
J Neurol; 2024 Jun; 271(6):3309-3320. PubMed ID: 38472397
[TBL] [Abstract][Full Text] [Related]
2. Clinical and anamnestic features of patients with systemic vasculitis: a single-center retrospective study.
Auanassova A; Yessirkepov M
Rheumatol Int; 2024 Apr; 44(4):687-692. PubMed ID: 38319375
[TBL] [Abstract][Full Text] [Related]
3. Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study.
Rodriguez-Pla A; Rossello-Urgell J
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919526
[TBL] [Abstract][Full Text] [Related]
4. Systemic vasculitis: one year in review 2024.
Treppo E; Monti S; Delvino P; Marvisi C; Ricordi C; La Rocca G; Moretti M; Italiano N; Di Cianni F; Ferro F; Muratore F; Baldini C; Talarico R; Quartuccio L; Salvarani C
Clin Exp Rheumatol; 2024 Apr; 42(4):771-781. PubMed ID: 38683204
[TBL] [Abstract][Full Text] [Related]
5. JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides.
Khan S
Clin Med (Lond); 2021 Mar; 21(2):e241-e242. PubMed ID: 33762397
[No Abstract] [Full Text] [Related]
6. Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis.
Redondo-Rodriguez R; Mena-Vázquez N; Cabezas-Lucena AM; Manrique-Arija S; Mucientes A; Fernández-Nebro A
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566698
[TBL] [Abstract][Full Text] [Related]
7. Large-vessel vasculitis.
Pugh D; Karabayas M; Basu N; Cid MC; Goel R; Goodyear CS; Grayson PC; McAdoo SP; Mason JC; Owen C; Weyand CM; Youngstein T; Dhaun N
Nat Rev Dis Primers; 2022 Jan; 7(1):93. PubMed ID: 34992251
[TBL] [Abstract][Full Text] [Related]
8. Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate: reply.
Stamatis P; Turkiewicz A; Englund M; Turesson C; Mohammad AJ
Rheumatology (Oxford); 2021 Nov; 60(11):e423-e424. PubMed ID: 34270676
[No Abstract] [Full Text] [Related]
9. A systematic review and meta-analysis of the incidence rate of Takayasu arteritis.
Rutter M; Bowley J; Lanyon PC; Grainge MJ; Pearce FA
Rheumatology (Oxford); 2021 Nov; 60(11):4982-4990. PubMed ID: 33944899
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate.
Stamatis P; Turkiewicz A; Englund M; Turesson C; Mohammad AJ
Rheumatology (Oxford); 2021 Dec; 61(1):146-153. PubMed ID: 33742665
[TBL] [Abstract][Full Text] [Related]
11. An update on the general management approach to common vasculitides.
Hng M; Zhao SS; Moots RJ
Clin Med (Lond); 2020 Nov; 20(6):572-579. PubMed ID: 33199323
[TBL] [Abstract][Full Text] [Related]
12. ANCA-associated vasculitis.
Kitching AR; Anders HJ; Basu N; Brouwer E; Gordon J; Jayne DR; Kullman J; Lyons PA; Merkel PA; Savage COS; Specks U; Kain R
Nat Rev Dis Primers; 2020 Aug; 6(1):71. PubMed ID: 32855422
[TBL] [Abstract][Full Text] [Related]
13. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
14. Rheumatology in the Middle East in 2017: clinical challenges and research.
Watad A; Al-Saleh J; Lidar M; Amital H; Shoenfeld Y
Arthritis Res Ther; 2017 Jun; 19(1):149. PubMed ID: 28666485
[TBL] [Abstract][Full Text] [Related]
15. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.
Nesher G; Breuer GS
Rambam Maimonides Med J; 2016 Oct; 7(4):. PubMed ID: 27824543
[TBL] [Abstract][Full Text] [Related]
16. The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study.
Nesher G; Ben-Chetrit E; Mazal B; Breuer GS
J Rheumatol; 2016 Jun; 43(6):1072-7. PubMed ID: 27084915
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
[TBL] [Abstract][Full Text] [Related]
18. New features of disease after diagnosis in 6 forms of systemic vasculitis.
Grayson PC; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Monach PA; Seo P; Specks U; Ytterberg SR; Merkel PA;
J Rheumatol; 2013 Nov; 40(11):1905-12. PubMed ID: 23908447
[TBL] [Abstract][Full Text] [Related]
19. Current concept and epidemiology of systemic vasculitides.
Katsuyama T; Sada KE; Makino H
Allergol Int; 2014 Dec; 63(4):505-13. PubMed ID: 25339434
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
